Perceptive Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Perceptive Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-236	Closed	-$24K	–	188
2017 Q1	$24K	Hold	236	–	–	﹤0.01%	142
2016 Q4	$25K	Sell	236 -13,459	-98%	-$1.57M	﹤0.01%	156
2016 Q3	$1.71M	Sell	13,695 -305	-2%	-$36K	0.11%	91
2016 Q2	$1.49M	Hold	14,000	–	–	0.1%	93
2016 Q1	$1.6M	Buy	+14,000	New	+$1.64M	0.14%	91
2015 Q3	–	Sell	-147,604	Closed	-$17M	–	203
2015 Q2	$17M	Buy	147,604 +77,604	+111%	+$8.15M	1.02%	25
2015 Q1	$6.69M	Sell	70,000 -4,023	-5%	-$301K	0.52%	43
2014 Q4	$4.98M	Buy	74,023 +71,623	+2,984%	+$4.44M	0.42%	54
2014 Q3	$130K	Hold	2,400	–	–	0.01%	100
2014 Q2	$107K	Buy	+2,400	New	+$98K	0.01%	99

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Perceptive Advisors's CBPO Position: Q2 2017 in Review

Perceptive Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 236 shares — an estimated $24K sold.

Perceptive Advisors first reported a position in CBPO in Q2 2014 and held it in 10 quarters. The position peaked at $17M in Q2 2015. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Perceptive Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Perceptive Advisors sold 236 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $24K.
Perceptive Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 10 quarters.
Perceptive Advisors's China Biologic Products Holdings, Inc. position peaked at $17M in Q2 2015.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.